Exploratory Study Using Nanotechnology to Detect Biomarkers of Parkinson's Disease From Exhaled Breath
-
- STATUS
- Not Recruiting
-
- participants needed
- 41
-
- sponsor
- Rambam Health Care Campus
Updated on 22 July 2024
Accepts healthy volunteers
Summary
Parkinson's disease is diagnosed clinically, because biomarkers that may help in diagnosis and differential diagnosis are not yet available. Exhaled breath testing may yield a "breath-print" that can be used to distinguish healthy and diseased states.
Details
| Condition | Parkinson's Disease, Parkinsonism |
|---|---|
| Age | 30years or above |
| Treatment | Collection of exhaled breath |
| Clinical Study Identifier | NCT01246336 |
| Sponsor | Rambam Health Care Campus |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.